文献速递艾滋病与性传播感染病毒性肝炎

2001-2019年美国HIV感染者癌症发病率趋势的种族/民族及风险组差异

Differences in Trends in Cancer Incidence Rates Among People With HIV During 2001-2019 by Race and Ethnicity and by Risk Group in the United States.
PubMed 文献 · Clin Infect Dis · 2025-01-01

该研究利用2001-2019年HIV/AIDS癌症匹配研究数据,分析≥20岁HIV感染者癌症发病率的时间趋势。结果显示,部分癌症的年龄标化发病率趋势因种族/民族和风险组而异,例如白人感染者肝癌发病率每5年下降23%,黑人下降11%,西班牙裔下降18%。研究结论指出,霍奇金淋巴瘤、肺癌、肝癌和宫颈癌的发病率趋势在种族/民族组间存在差异,霍奇金淋巴瘤、肺癌、肛门癌和肝癌的发病率趋势在风险组间存在差异。

要点

  • 白人、黑人和西班牙裔HIV感染者的肝癌发病率下降幅度不同。
  • 肛门癌发病率在男男性行为者中下降,在注射吸毒者中稳定,在其他风险组中上升。
  • 2001-2004至2015-2019年间,霍奇金淋巴瘤和肝癌的种族/民族相对差异增大,非霍奇金淋巴瘤的相对差异减小。

核心结论

  • 2001-2019年美国HIV感染者中,霍奇金淋巴瘤、肺癌、肝癌和宫颈癌的发病率趋势因种族/民族而异;霍奇金淋巴瘤、肺癌、肛门癌和肝癌的发病率趋势因风险组而异。
  • 未来工作应探究这些趋势差异的潜在原因。

研究设计与样本

  • 研究使用HIV/AIDS癌症匹配研究中2001-2019年年龄≥20岁的HIV感染者数据。
  • 采用泊松回归评估各癌症部位的发病率时间趋势,按种族/民族和风险组分层,并调整年龄、登记处和性别。
  • 还估计了2001-2004年和2015-2019年按种族/民族和风险组分层的调整率比。

主要发现

  • 肝癌发病率每5年下降:白人HIV感染者下降23%,黑人下降11%,西班牙裔下降18%。
  • 肛门癌发病率在男男性行为者中下降,在注射吸毒者中稳定,在其他风险组中上升。
  • 2001-2004年至2015-2019年间,按种族/民族,霍奇金淋巴瘤和肝癌的相对差异增大,非霍奇金淋巴瘤的相对差异减小。
  • 按风险组,非霍奇金淋巴瘤和肝癌的相对差异增大,霍奇金淋巴瘤、肺癌和肛门癌的相对差异减小。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unclear whether cancer risk among people with human immunodeficiency virus (HIV, PWH) has declined equally across all racial/ethnic and transmission risk groups. METHODS: We used data on PWH aged ≥20 years from the HIV/AIDS Cancer Match Study during 2001-2019. We used Poisson regression to assess time trends in incidence rates for each cancer site by racial/ethnicity and risk groups, adjusting for age, registry, and sex. We also estimated adjusted rate ratios across racial and ethnic and risk groups in 2001-2004 and 2015-2019. RESULTS: Trends in age-standardized rates differed across racial/ethnic groups and across risk groups for some cancers. For example, liver cancer rates declined 23% per 5-year period among White PWH, 11% among Black PWH, and 18% among Hispanic PWH. Anal cancer rates declined among men who have sex with men, were stable among people who inject drugs, and increased among other risk groups. Between 2001-2004 and 2015-2019, the relative difference in cancer incidence rates by race/ethnicity increased for Hodgkin lymphoma (HL) and liver cancer but decreased for non-Hodgkin lymphoma (NHL); by risk group, relative differences increased for NHL and liver cancer and decreased for HL and lung and anal cancers. CONCLUSIONS: Among PWH in the United States during 2001-2019, HL, lung, liver, and cervical cancer rate trends were different across racial/ethnic groups. HL, lung, anal, and liver cancer rate trends were different across risk groups. Future work should examine underlying causes of the differences in trends.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Luo Q, Horner MJ, Haas CB, et al. Differences in Trends in Cancer Incidence Rates Among People With HIV During 2001-2019 by Race and Ethnicity and by Risk Group in the United States. Clin Infect Dis. 2025. PMID: 39509333. doi:10.1093/cid/ciae555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。